Evidence that recurrent Group A streptococcus tonsillitis is an immunosusceptibility disease involving antibody deficiency and aberrant Tfh cells
暂无分享,去创建一个
V. Nizet | A. Sette | S. Crotty | G. Seumois | P. Vijayanand | C. Ottensmeier | C. L. Lindestam Arlehamn | J. Dan | C. Havenar-Daughton | M. Bothwell | Kayla Kendric | K. Kaushik | Christopher N. LaRock | R. Cutress | M. Brigger | D. Layfield | E. Anderson | Rita Al-Kolla | S. L. Rosales | Ericka Anderson | Christian Ottensmier | Kirti Kaushik
[1] Jun Huang,et al. The receptor repertoire and functional profile of follicular T cells in HIV-infected lymph nodes , 2018, Science Immunology.
[2] Susan M. Corley,et al. STAT3 regulates cytotoxicity of human CD57+ CD4+ T cells in blood and lymphoid follicles , 2018, Scientific Reports.
[3] A. Schilder,et al. Addressing the Challenges in Tonsillectomy Research to Inform Health Care Policy: A Review , 2017, JAMA otolaryngology-- head & neck surgery.
[4] S. Haeryfar,et al. Nasopharyngeal infection by Streptococcus pyogenes requires superantigen-responsive Vβ-specific T cells , 2017, Proceedings of the National Academy of Sciences.
[5] R. Ahmed,et al. Dynamics of SIV-specific CXCR5+ CD8 T cells during chronic SIV infection , 2017, Proceedings of the National Academy of Sciences.
[6] Michael Y. Gerner,et al. Follicular CD8 T cells accumulate in HIV infection and can kill infected cells in vitro via bispecific antibodies , 2017, Science Translational Medicine.
[7] S. Mallal,et al. Human CD4+ T Cell Responses to an Attenuated Tetravalent Dengue Vaccine Parallel Those Induced by Natural Infection in Magnitude, HLA Restriction, and Antigen Specificity , 2016, Journal of Virology.
[8] S. Tangye,et al. Immunology: Cytotoxic T cells that escape exhaustion , 2016, Nature.
[9] Di Wu,et al. CXCR5+ follicular cytotoxic T cells control viral infection in B cell follicles , 2016, Nature Immunology.
[10] Matheus C. Bürger,et al. Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy , 2016, Nature.
[11] Alessandro Sette,et al. A Cytokine-Independent Approach To Identify Antigen-Specific Human Germinal Center T Follicular Helper Cells and Rare Antigen-Specific CD4+ T Cells in Blood , 2016, The Journal of Immunology.
[12] S. Crotty,et al. Activin A programs the differentiation of human TFH cells , 2016, Nature Immunology.
[13] R. D. Di Francesco,et al. Asymptomatic Group A Streptococcus carriage in children with recurrent tonsillitis and tonsillar hypertrophy. , 2016, International journal of pediatric otorhinolaryngology.
[14] Bali Pulendran,et al. Cytokine-Independent Detection of Antigen-Specific Germinal Center T Follicular Helper Cells in Immunized Nonhuman Primates Using a Live Cell Activation-Induced Marker Technique , 2016, The Journal of Immunology.
[15] I. Maclennan,et al. Follicular Helper T Cells. , 2016, Annual review of immunology.
[16] M. Pichichero,et al. A Reappraisal of the Minimum Duration of Antibiotic Treatment Before Approval of Return to School for Children With Streptococcal Pharyngitis , 2015, The Pediatric infectious disease journal.
[17] V. Nizet,et al. Group A Streptococcal M1 Protein Sequesters Cathelicidin to Evade Innate Immune Killing. , 2015, Cell host & microbe.
[18] Weiqun Peng,et al. LEF-1 and TCF-1 orchestrate TFH differentiation by regulating differentiation circuits upstream of the transcriptional repressor Bcl6 , 2015, Nature Immunology.
[19] Ravi V. Kolla,et al. Dengue virus infection elicits highly polarized CX3CR1+ cytotoxic CD4+ T cells associated with protective immunity , 2015, Proceedings of the National Academy of Sciences.
[20] L. Picker,et al. A B cell follicle sanctuary permits persistent productive SIV infection in elite controllers , 2014, Nature Medicine.
[21] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[22] S. Crotty. T follicular helper cell differentiation, function, and roles in disease. , 2014, Immunity.
[23] Paul Theodor Pyl,et al. HTSeq—a Python framework to work with high-throughput sequencing data , 2014, bioRxiv.
[24] Daan Van Brusselen,et al. Streptococcal pharyngitis in children: to treat or not to treat? , 2014, European Journal of Pediatrics.
[25] Bjoern Peters,et al. Epigenomic analysis of primary human T cells reveals enhancers associated with TH2 memory cell differentiation and asthma susceptibility , 2014, Nature Immunology.
[26] S. Haeryfar,et al. Bacterial Superantigens Promote Acute Nasopharyngeal Infection by Streptococcus pyogenes in a Human MHC Class II-Dependent Manner , 2014, PLoS pathogens.
[27] Timothy C. Barnett,et al. Disease Manifestations and Pathogenic Mechanisms of Group A Streptococcus , 2014, Clinical Microbiology Reviews.
[28] Åsa K. Björklund,et al. Full-length RNA-seq from single cells using Smart-seq2 , 2014, Nature Protocols.
[29] Bjoern Peters,et al. A strategy to determine HLA class II restriction broadly covering the DR, DP, and DQ allelic variants most commonly expressed in the general population , 2013, Immunogenetics.
[30] A. Bisno,et al. Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[31] Ravi V. Kolla,et al. T Cell Responses to Known Allergen Proteins Are Differently Polarized and Account for a Variable Fraction of Total Response to Allergen Extracts , 2012, The Journal of Immunology.
[32] J. Wilson,et al. Streptococcus pyogenes infection of tonsil explants is associated with a human β-defensin 1 response from control but not recurrent acute tonsillitis patients. , 2012, Molecular oral microbiology.
[33] É. Marijon,et al. Rheumatic heart disease , 2012, The Lancet.
[34] M. Bonneville,et al. Ex vivo measurement of the cytotoxic capacity of human primary antigen-specific CD8 T cells. , 2012, Journal of immunological methods.
[35] T. R. Peters,et al. Detection of group A Streptococcus in tonsils from pediatric patients reveals high rate of asymptomatic streptococcal carriage , 2012, BMC Pediatrics.
[36] J. Musser,et al. Group A Streptococcus emm Gene Types in Pharyngeal Isolates, Ontario, Canada, 2002–2010 , 2011, Emerging infectious diseases.
[37] S. Crotty,et al. Follicular helper CD4 T cells (TFH). , 2011, Annual review of immunology.
[38] Robert A. Edwards,et al. Quality control and preprocessing of metagenomic datasets , 2011, Bioinform..
[39] P. Wilkins,et al. Public Health Implications of Cysticercosis Acquired in the United States , 2011, Emerging infectious diseases.
[40] R. Rosenfeld,et al. Clinical Practice Guideline: Tonsillectomy in Children , 2010, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[41] Gonçalo R. Abecasis,et al. The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..
[42] Lior Pachter,et al. Sequence Analysis , 2020, Definitions.
[43] J. Carlin,et al. Normal Ranges of Streptococcal Antibody Titers Are Similar Whether Streptococci Are Endemic to the Setting or Not , 2008, Clinical and Vaccine Immunology.
[44] Ramy K. Aziz,et al. Rise and Persistence of Global M1T1 Clone of Streptococcus pyogenes , 2008, Emerging infectious diseases.
[45] M. Singh,et al. Evaluating the role of HLA-DQ polymorphisms on immune response to bacterial superantigens using transgenic mice. , 2007, Tissue antigens.
[46] J. Jeong,et al. Bacteriologic Comparison of Tonsil Core in Recurrent Tonsillitis and Tonsillar Hypertrophy , 2007, The Laryngoscope.
[47] B. Hirst,et al. Pili mediate specific adhesion of Streptococcus pyogenes to human tonsil and skin , 2007, Cellular microbiology.
[48] J. Musser,et al. New understanding of the group A Streptococcus pathogenesis cycle. , 2007, Trends in microbiology.
[49] D. Zavadska,et al. HLA class II DR and DQ genotypes and haplotypes associated with rheumatic fever among a clinically homogeneous patient population of Latvian children , 2007, Arthritis research & therapy.
[50] F. Oguz,et al. The role of HLA molecules in susceptibility to chronic rheumatic heart disease , 2006, International journal of immunogenetics.
[51] J. Carapetis,et al. The global burden of group A streptococcal diseases. , 2005, The Lancet. Infectious diseases.
[52] Rita Kansal,et al. Invasive M1T1 group A Streptococcus undergoes a phase‐shift in vivo to prevent proteolytic degradation of multiple virulence factors by SpeB , 2003, Molecular microbiology.
[53] D. Zavadska,et al. HLA class II associations with rheumatic heart disease among clinically homogeneous patients in children in Latvia , 2003, Arthritis research & therapy.
[54] Malak Kotb,et al. An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections , 2002, Nature Medicine.
[55] A. Norrby-Teglund,et al. Differential presentation of group A streptococcal superantigens by HLA class II DQ and DR alleles , 2002, European journal of immunology.
[56] Dwight R. Johnson,et al. The heterogeneity of endemic community pediatric group a streptococcal pharyngeal isolates and their relationship to invasive isolates. , 2002, The Journal of infectious diseases.
[57] Dwight R. Johnson,et al. Dynamic epidemiology of group A streptococcal serotypes associated with pharyngitis , 2001, The Lancet.
[58] Ramy K. Aziz,et al. Reciprocal, Temporal Expression of SpeA and SpeB by Invasive M1T1 Group A Streptococcal Isolates In Vivo , 2001, Infection and Immunity.
[59] Mark H. Ebell,et al. Does This Patient Have Strep Throat , 2000 .
[60] M. Cunningham,et al. Pathogenesis of group A streptococcal infections. , 2000, Clinical microbiology reviews.
[61] Malak Kotb,et al. Genetic Relatedness and Superantigen Expression in Group A Streptococcus Serotype M1 Isolates from Patients with Severe and Nonsevere Invasive Diseases , 2000, Infection and Immunity.
[62] J. Schellekens,et al. Invasive group A streptococcal disease in the Netherlands: evidence for a protective role of anti-exotoxin A antibodies. , 2000, The Journal of infectious diseases.
[63] J. Andersson,et al. Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome. , 1999, The Journal of infectious diseases.
[64] B. Schwartz,et al. Risk Factors in the Pathogenesis of Invasive Group A Streptococcal Infections: Role of Protective Humoral Immunity , 1999, Infection and Immunity.
[65] M. Pichichero,et al. Recurrent group A streptococcal tonsillopharyngitis. , 1998, The Pediatric infectious disease journal.
[66] M. Kleerebezem,et al. Controlled overproduction of proteins by lactic acid bacteria. , 1997, Trends in biotechnology.
[67] A. Norrby-Teglund,et al. Relation between low capacity of human sera to inhibit streptococcal mitogens and serious manifestation of disease. , 1994, The Journal of infectious diseases.
[68] J M Scheller,et al. The rational clinical examination. , 1992, JAMA.
[69] A. Jones,et al. American Academy of Otolaryngology-Head and Neck Surgery Foundation, Inc. , 2004 .
[70] P. Soulié,et al. RHEUMATIC HEART DISEASE , 1954, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris.
[71] M. Nussenzweig,et al. Dopamine in germinal centers , 2017, Nature Immunology.
[72] M H Ebell,et al. The rational clinical examination. Does this patient have strep throat? , 2000, JAMA.
[73] B. Schwartz,et al. Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity. , 1999, Infection and immunity.
[74] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .